The Microbiome and Tuberculosis: Early Evidence for Cross Talk

por Sivaranjani Namasivayam, Alan Sher, Michael S. Glickman, Matthew F. Wipperman
Publicado 2018

The DnaK Chaperone System Buffers the Fitness Cost of Antibiotic Resistance Mutations in Mycobacteria

por Allison Fay, John Philip, Priya Saha, Ronald C. Hendrickson, Michael S. Glickman, Kristin Burns-Huang
Publicado 2021

Two Accessory Proteins Govern MmpL3 Mycolic Acid Transport in Mycobacteria

por Allison Fay, Nadine Czudnochowski, Jeremy M. Rock, Jeffrey R. Johnson, Nevan J. Krogan, Oren Rosenberg, Michael S. Glickman
Publicado 2019

Antibiotic treatment for Tuberculosis induces a profound dysbiosis of the microbiome that persists long after therapy is completed

por Matthew F. Wipperman, Daniel W. Fitzgerald, Marc Antoine Jean Juste, Ying Taur, Sivaranjani Namasivayam, Alan Sher, James M. Bean, Vanni Bucci, Michael S. Glickman
Publicado 2017

Structure of ubiquitylated-Rpn10 provides insight into its autoregulation mechanism

por Tal Keren-Kaplan, Lee Zeev Peters, Olga Levin-Kravets, Ilan Attali, Oded Kleifeld, Noa Shohat, Shay Artzi, Ori Zucker, Inbar Pilzer, Noa Reis, Michael H. Glickman, Shay Ben-Aroya, Gali Prag
Publicado 2016

Gastrointestinal microbiota composition predicts peripheral inflammatory state during treatment of human tuberculosis

por Matthew F. Wipperman, Shakti K. Bhattarai, Charles Kyriakos Vorkas, Venkata Suhas Maringati, Ying Taur, Laurent Mathurin, Katherine McAulay, Stalz Charles Vilbrun, Daphie Francois, James Bean, Kathleen F. Walsh, Carl Nathan, Daniel W. Fitzgerald, Michael S. Glickman, Vanni Bucci
Publicado 2021

Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism

por James Peek, Mirjana Lilic, Daniel Montiel, Aleksandr Milshteyn, Ian Woodworth, John B. Biggins, Melinda A. Ternei, Paula Y. Calle, Michael Danziger, Thulasi Warrier, Kohta Saito, Nathaniel Braffman, Allison Fay, Michael S. Glickman, Seth A. Darst, Elizabeth A. Campbell, Sean F. Brady
Publicado 2018